[go: up one dir, main page]

SK695A3 - Heterocyclic compounds method of their production and using - Google Patents

Heterocyclic compounds method of their production and using

Info

Publication number
SK695A3
SK695A3 SK6-95A SK695A SK695A3 SK 695 A3 SK695 A3 SK 695A3 SK 695 A SK695 A SK 695A SK 695 A3 SK695 A3 SK 695A3
Authority
SK
Slovakia
Prior art keywords
group
substituted
compound
alkyl
aryl
Prior art date
Application number
SK6-95A
Other languages
Slovak (sk)
Inventor
David Haigh
John Thomas Sime
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929214185A external-priority patent/GB9214185D0/en
Priority claimed from GB929227030A external-priority patent/GB9227030D0/en
Priority claimed from GB939311027A external-priority patent/GB9311027D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK695A3 publication Critical patent/SK695A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A compound of formula (I): <CHEM> or a tautomeric form thereof and/or a pharmaceutically acceptable salt thereof, and/or a pharmaceutically acceptable solvate thereof, wherein: A<1> represents a substituted or unsubstituted aromatic heterocyclyl group; A<2> represents a benzene ring having three optional substituents; A<3> represents a moiety of formula -(CH2)m-CH(OR<1>)- wherein R<1> represents substituted or unsubstituted alkyl, aryl, aralkyl or alkylcarbonyl and m represents an integer in the range of from 1 to 5, or A<3> represents a moiety of formula - (CH2)m-1-CH=C(OR<1>)- wherein R<1> and m are as defined above; R<2> represents OR<3> wherein R<3> represents hydrogen, alkyl, aryl or aralkyl or R<2> represents an aromatic heterocyclyl group or -NR<4>R<5> wherein R<4> and R<5> each independently represent hydrogen, alkyl or alkylcarbonyl or R<4> and R<5> together with the nitrogen atom to which they are attached form a heterocyclic ring, providing that R<2> represents an aromatic heterocyclyl group only when Y as defined below represents a bond ; X represents NR wherein R represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; Y represents CO or CS or a bond providing that Y represents a bond only when R<2> represents the above mentioned aromatic heterocyclyl group; and n represents an integer in the range of from 2 to 6; a process for preparing such a compound, a composition comprising such a compound and the use of such a compound and composition in medicine.
SK6-95A 1992-07-03 1993-06-29 Heterocyclic compounds method of their production and using SK695A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929214185A GB9214185D0 (en) 1992-07-03 1992-07-03 Novel compounds
GB929227030A GB9227030D0 (en) 1992-12-29 1992-12-29 Novel compounds
GB939311027A GB9311027D0 (en) 1993-05-28 1993-05-28 Novel compounds
PCT/GB1993/001363 WO1994001420A1 (en) 1992-07-03 1993-06-29 Heterocyclic compounds as pharmaceutical

Publications (1)

Publication Number Publication Date
SK695A3 true SK695A3 (en) 1995-07-11

Family

ID=27266276

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6-95A SK695A3 (en) 1992-07-03 1993-06-29 Heterocyclic compounds method of their production and using

Country Status (19)

Country Link
US (2) US6048883A (en)
EP (2) EP0648212B1 (en)
JP (1) JPH07508747A (en)
KR (1) KR950702545A (en)
CN (2) CN1042532C (en)
AT (1) ATE207470T1 (en)
AU (1) AU678974B2 (en)
CA (1) CA2139442A1 (en)
CZ (1) CZ1095A3 (en)
DE (1) DE69331010D1 (en)
FI (1) FI950016A7 (en)
HU (1) HUT71247A (en)
MX (1) MX9303981A (en)
NO (2) NO305318B1 (en)
NZ (1) NZ253742A (en)
PL (2) PL174610B1 (en)
RU (1) RU2134686C1 (en)
SK (1) SK695A3 (en)
WO (1) WO1994001420A1 (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311644D0 (en) * 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
GB9311661D0 (en) * 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
GB9315148D0 (en) * 1993-07-22 1993-09-08 Smithkline Beecham Plc Novel compounds
GB9326171D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Novel compounds
WO1996004261A1 (en) * 1994-07-29 1996-02-15 Smithkline Beecham Plc Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
CN1158123A (en) * 1994-07-29 1997-08-27 史密丝克莱恩比彻姆有限公司 Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
US5847008A (en) * 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US6090836A (en) * 1996-02-02 2000-07-18 Merck & Co., Inc. Benzisoxazole-derived antidiabetic compounds
US6020382A (en) * 1996-02-02 2000-02-01 Merck & Co., Inc. Method of treating diabetes and related disease states
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
CN1233241A (en) * 1996-08-19 1999-10-27 日本烟草产业株式会社 Propionic acid derivatives and uses thereof
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
EP2266576A1 (en) 1997-06-18 2010-12-29 SmithKline Beecham Limited Treatment of diabetes with thiazolidinedione and sulphonylurea
US6130214A (en) 1997-10-27 2000-10-10 Dr. Reddy's Research Foundation Benzothiazin and benzoxazin derivatives; their preparation and uses
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
GB2380997B (en) * 1997-10-27 2003-07-02 Reddys Lab Ltd Dr Novel aryl-oxysubstituted alkyl carboxylic acids; process for their preparation and pharmaceutical compositions containing them
US6265401B1 (en) 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
CA2307068C (en) 1997-10-27 2007-04-10 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) * 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU749505B2 (en) * 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
AU1120599A (en) * 1998-04-23 1999-03-08 Dr. Reddy's Research Foundation New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
SE9801992D0 (en) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
ID28783A (en) 1998-11-12 2001-07-05 Smithkline Beecham Plc PHARMACEUTICAL COMPOSITION FOR MODIFICATED RELEASE FROM OTHER INSULIN PEMEKA AND ANTIDIABETES
AR023700A1 (en) 1998-11-12 2002-09-04 Smithkline Beecham Plc A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN SENSITIZER
US7000106B2 (en) * 1999-03-26 2006-02-14 Siemens Communications, Inc. Methods and apparatus for kernel mode encryption of computer telephony
US6972294B1 (en) 1999-04-20 2005-12-06 Novo Nordisk, A/S Compounds, their preparation and use
DE60005973T2 (en) 1999-08-27 2004-05-13 Eli Lilly And Co., Indianapolis BIARYL-OXA (THIA) ZOL DERIVATIVES AND THEIR USE AS PPARS MODULATORS
SE9904415D0 (en) * 1999-12-03 1999-12-03 Astra Ab New process
UA73546C2 (en) * 2000-01-19 2005-08-15 Cadila Healthcare Ltd Compounds revealing hypolipidemic activity, a method for the preparation thereof (variants), pharmaceutical composition based thereon, intermediary compound and a method for the preparation thereof
US6555577B1 (en) 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
CA2396372A1 (en) * 2000-01-28 2001-08-02 Novo Nordisk A/S Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
US6569901B2 (en) 2000-01-28 2003-05-27 Novo Nordisk A/S Alkynyl-substituted propionic acid derivatives, their preparation and use
US6509374B2 (en) 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
US6559335B2 (en) 2000-09-22 2003-05-06 Dr. Reddy's Laboratories Limited Process for the preparation of 3-aryl-2-hydroxy propanoic acid
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
RU2278859C2 (en) 2001-05-15 2006-06-27 Ф.Хоффманн-Ля Рош Аг Oxazole derivatives substituted with carboxylic acids as ppar-alpha and ppar-gamma activators in diabetes treatment
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7067530B2 (en) 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
US6869967B2 (en) 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
WO2003016265A1 (en) 2001-08-17 2003-02-27 Eisai Co., Ltd. Cyclic compound and ppar agonist
US7220877B2 (en) 2001-10-17 2007-05-22 Novo Nordisk A/S Compounds, their preparation and use
AU2002351752A1 (en) 2001-12-29 2003-07-30 Novo Nordisk A/S Combined use of a glp-1 compound and another drug for treating dyslipidemia
RU2228753C2 (en) * 2002-01-31 2004-05-20 Пермская государственная фармацевтическая академия Phthalic acid isonicotinoyl hydrazide eliciting hypoglycemic activity
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
CA2495942C (en) 2002-08-30 2010-03-23 F. Hoffmann-La Roche Ag Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
WO2004024726A1 (en) 2002-09-12 2004-03-25 F. Hoffmann-La Roche Ag N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
BR0316556A (en) 2002-11-25 2005-10-04 Hoffmann La Roche Compounds, process for preparing a compound, pharmaceutical composition comprising such compound, its use and method for treating and / or prophylaxis of diseases that are modulated by ppar (alpha) and / or ppary agonists
US7816385B2 (en) 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
AU2004247023A1 (en) * 2003-05-16 2004-12-23 Ambit Biosciences Corporation Heterocyclic compounds and uses thereof
PL371841A1 (en) * 2004-12-20 2006-06-26 ADAMED Sp.z o.o. New derivatives of 3-phenylpropionic acid
US20090088419A1 (en) * 2005-02-25 2009-04-02 Takeda Pharmaceutical Company Limited Pyridyl acetic acid compounds
WO2008117982A1 (en) * 2007-03-28 2008-10-02 Crystal Genomics, Inc. Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same
JPWO2008139879A1 (en) * 2007-04-26 2010-07-29 ファルマフロンティア株式会社 G protein-coupled receptor inhibitor and pharmaceutical
RU2429728C1 (en) * 2010-03-09 2011-09-27 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия (ГОУ ВПО ВГТА) Dry protein-and-vegetative mixture for oxygen cocktail production
MX350611B (en) 2011-01-31 2017-09-11 Cadila Healthcare Ltd Treatment for lipodystrophy.
CN105377246B (en) 2013-04-22 2018-03-20 卡迪拉保健有限公司 For non-alcohol fatty liver (NAFLD) new compositions
MX2015016403A (en) 2013-05-30 2016-04-11 Cadila Healthcare Ltd A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities.
TW201636015A (en) 2013-07-05 2016-10-16 卡地拉保健有限公司 Synergistic compositions
IN2013MU02470A (en) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
CN103467406B (en) * 2013-09-03 2014-12-17 浙江医药高等专科学校 Halogen-substituted tetrazole carboxylic acid compounds, and preparation method and application thereof
CN103467405B (en) * 2013-09-03 2015-01-07 浙江医药高等专科学校 A class of tetrazole carboxylic acid compounds, its preparation method and use
CN103467408B (en) * 2013-09-03 2015-01-21 浙江医药高等专科学校 Tetrazole carboxylic acid compounds and application thereof
CN103467409B (en) * 2013-09-03 2015-01-07 浙江医药高等专科学校 Substituted tetrazole carboxylic acid compounds and application thereof
CN103467407B (en) * 2013-09-03 2015-04-22 浙江医药高等专科学校 Tetrazole carboxylic acid compounds and application thereof
US10112898B2 (en) 2013-09-06 2018-10-30 Cadila Healthcare Limited Process for the preparation of saroglitazar pharmaceutical salts
US10385017B2 (en) 2015-10-14 2019-08-20 Cadila Healthcare Limited Pyrrole compound, compositions and process for preparation thereof
ES2894261T3 (en) 2016-12-09 2022-02-14 Cadila Healthcare Ltd Treatment of primary biliary cholangitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
DE10199003I1 (en) * 1987-09-04 2003-06-12 Beecham Group Plc Substituted thiazolidine ion derivatives
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
CZ1095A3 (en) 1995-10-18
MX9303981A (en) 1994-04-29
US5869495A (en) 1999-02-09
US6048883A (en) 2000-04-11
RU2134686C1 (en) 1999-08-20
NO950009D0 (en) 1995-01-02
AU678974B2 (en) 1997-06-19
HUT71247A (en) 1995-11-28
CA2139442A1 (en) 1994-01-20
NO950009L (en) 1995-03-02
NO990227D0 (en) 1999-01-19
NO305318B1 (en) 1999-05-10
NZ253742A (en) 1997-06-24
ATE207470T1 (en) 2001-11-15
FI950016A0 (en) 1995-01-02
AU4506893A (en) 1994-01-31
RU94046169A (en) 1996-10-27
EP1000938A1 (en) 2000-05-17
CN1042532C (en) 1999-03-17
PL174610B1 (en) 1998-08-31
EP0648212B1 (en) 2001-10-24
NO990227L (en) 1995-03-02
KR950702545A (en) 1995-07-29
CN1215724A (en) 1999-05-05
EP0648212A1 (en) 1995-04-19
HU9500006D0 (en) 1995-03-28
DE69331010D1 (en) 2001-11-29
PL307087A1 (en) 1995-05-02
FI950016A7 (en) 1995-03-02
WO1994001420A1 (en) 1994-01-20
PL176885B1 (en) 1999-08-31
JPH07508747A (en) 1995-09-28
CN1095716A (en) 1994-11-30

Similar Documents

Publication Publication Date Title
SK695A3 (en) Heterocyclic compounds method of their production and using
PT88410A (en) PROCESS FOR PREPARING THIAZOLIDINEDIONE DERIVATIVES
GB8919434D0 (en) Novel compounds
GB8919417D0 (en) Novel compounds
IL88122A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing them
EP0356214A3 (en) Thiazolidine dione derivatives
HU902839D0 (en) Process for producing acriloyl-substituted pyrrole derivatives and pharmaceutical preparatives containing them
GB9308487D0 (en) Novel compounds
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
UA50722C2 (en) Nitrobenzamides, method for their production (variants), pharmaceutical composition
DE69625795D1 (en) Thiazolidinedione derivatives with antidiabetic, hypolipidemic and antihypertensive properties, processes for their preparation and pharmaceutical compositions containing them
MX15697A (en) HETEROTETRACICLIC DERIVATIVES OF LACTAMA AND PROCESS FOR ITS PREPARATION
NZ240272A (en) Piperazine derivatives; pharmaceutical compositions and preparatory processes
ES2024332A6 (en) New sulfonamides as antifungal agents.